Thermo Fisher Scientific (BMV:TMO *) - Aandelenkoers, Nieuws & Analyse

TMO * Overzicht aandelen

Thermo Fisher Scientific Inc. levert oplossingen voor de biowetenschappen, analytische instrumenten, diagnostische specialiteiten, laboratoriumproducten en biofarmaceutische diensten in Noord-Amerika, Europa, Azië-Pacific en internationaal. Meer informatie

TMO * fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	2/6
Prestaties in het verleden	4/6
Financiële gezondheid	3/6
Dividenden	0/6

Beloningen

Verhandeld tegen 18% onder onze schatting van de reële waarde

De winst zal naar verwachting met 11.48% per jaar groeien

De winst groeide het afgelopen jaar met 3.3%

Analisten zijn het erover eens dat de aandelenkoers met 27.4% zal stijgen

Risicoanalyse

Heeft een hoog schuldenniveau

Thermo Fisher Scientific Inc. Concurrenten

Danaher

NYSE:DHR

US$170.3b

Agilent Technologies

NYSE:A

US$38.5b

Lonza Group

SWX:LONN

CHF 37.7b

IQVIA Holdings

NYSE:IQV

US$36.6b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Thermo Fisher Scientific
Historische aandelenkoersen
Huidige aandelenkoers	US$10,530.33
52 Week Hoogtepunt	US$12,500.00
52 Week Laag	US$8,333.52
Bèta	0.79
11 maand verandering	-5.58%
3 maanden verandering	-9.59%
1 Jaar Verandering	25.96%
33 jaar verandering	-24.86%
5 jaar verandering	72.63%
Verandering sinds IPO	587.93%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	TMO *	MX Life Sciences	MX Markt
7D	-0.6%	0%	0%
1Y	26.0%	0%	0%

Rendement versus industrie: TMO * overtrof de MX Life Sciences industrie, die het afgelopen jaar een rendement -0.2 % opleverde.

Rendement versus markt: TMO * overtrof de MX markt, die het afgelopen jaar een rendement opleverde van -4 %.

Prijsvolatiliteit

Is TMO *'s price volatile compared to industry and market?
TMO * volatility
TMO * Average Weekly Movement	4.1%
Life Sciences Industry Average Movement	0%
Market Average Movement	0%
10% most volatile stocks in MX Market	0%
10% least volatile stocks in MX Market	0%

Stabiele aandelenkoers: TMO * heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van TMO * is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1956	122,000	Marc Casper	www.thermofisher.com

Thermo Fisher Scientific Inc. levert life sciences oplossingen, analytische instrumenten, speciale diagnostica, laboratoriumproducten en biofarmaceutische diensten in Noord-Amerika, Europa, Azië-Pacific en internationaal. Het segment Life Sciences Solutions van het bedrijf biedt reagentia, instrumenten en verbruiksgoederen voor biologisch en medisch onderzoek, ontdekking en productie van medicijnen en vaccins, evenals diagnose van infecties en ziekten; en oplossingen voor biowetenschappen, genetische wetenschappen en bioproductie voor farmaceutische, biotechnologische, landbouw-, klinische, gezondheidszorg-, academische en overheidsmarkten. Het segment Analytische instrumenten levert instrumenten, verbruiksartikelen, software en diensten voor de farmaceutische, biotechnologische, academische, overheids-, milieu- en andere onderzoeks- en industriële markten, evenals klinische laboratoria.

Thermo Fisher Scientific Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Thermo Fisher Scientific zich tot de beurswaarde?
TMO * fundamentele statistieken
Marktkapitalisatie	Mex$4.02t
Inkomsten(TTM)	Mex$125.65b
Inkomsten(TTM)	Mex$867.77b

32.0x

Koers/Winstverhouding

4.6x

P/S-verhouding

Is TMO * overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
TMO * resultatenrekening (TTM)
Inkomsten	US$42.37b
Kosten van inkomsten	US$25.13b
Brutowinst	US$17.24b
Overige uitgaven	US$11.10b
Inkomsten	US$6.14b

Laatst gerapporteerde inkomsten

Sep 28, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	16.04
Brutomarge	40.68%
Nettowinstmarge	14.48%
Schuld/Eigen Vermogen Verhouding	71.9%

Hoe presteerde TMO * op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

0.3%

Huidig dividendrendement

9%

Uitbetalingsratio

Betaalt TMO * een betrouwbaar dividend?

Zie TMO * dividendgeschiedenis en benchmarks

Wanneer moet je TMO * kopen om een aanstaand dividend te ontvangen?
Thermo Fisher Scientific dividenddata
Ex Dividend Datum	Dec 13 2024
Betaaldatum dividend	Jan 15 2025
Dagen tot Ex-dividend	19 days
Dagen tot dividendbetaaldatum	52 days

Betaalt TMO * een betrouwbaar dividend?

Zie TMO * dividendgeschiedenis en benchmarks

TMO * Overzicht aandelen

Beloningen

Risicoanalyse

Thermo Fisher Scientific Inc. Concurrenten

NYSE:DHR

US$170.3b

NYSE:A

US$38.5b

SWX:LONN

CHF 37.7b

NYSE:IQV

US$36.6b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Thermo Fisher Scientific Inc. (NYSE:TMO) announces an Equity Buyback for $4,000 million worth of its shares.

Third quarter dividend of US$0.39 announced

Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2025

Third quarter 2024 earnings released: EPS: US$4.27 (vs US$4.44 in 3Q 2023)

Thermo Fisher Scientific Inc. Provides Earnings Guidance for the Year 2024

Thermo Fisher Scientific Introduces Fully Integrated Multimodal Analytical Scanning Transmission Electron Microscope to Advance Novel Research in Materials Science

Recent updates

Thermo Fisher Scientific Inc. (NYSE:TMO) announces an Equity Buyback for $4,000 million worth of its shares.

Third quarter dividend of US$0.39 announced

Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2025

Third quarter 2024 earnings released: EPS: US$4.27 (vs US$4.44 in 3Q 2023)

Thermo Fisher Scientific Inc. Provides Earnings Guidance for the Year 2024

Thermo Fisher Scientific Introduces Fully Integrated Multimodal Analytical Scanning Transmission Electron Microscope to Advance Novel Research in Materials Science

Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity

Thermo Fisher Scientific Inc. to Report Q3, 2024 Results on Oct 23, 2024

Upcoming dividend of US$0.39 per share

FDA Grants Thermo Fisher Scientific Inc.'s SeCore HLA Typing Kit 510(k) Clearance for Use as Companion Diagnostic with a T-Cell Receptor Therapy for Synovial Sarcoma

Thermo Fisher Scientific Inc. Announces Extended 510k Clearance of Freelite Assays for Evaluation of MGUS

Insider recently sold Mex$41m worth of stock

Thermo Fisher Scientific Inc. Showcases Diagnostics Innovation Across Therapeutic Areas at ADLM 2024

Second quarter 2024 earnings released: EPS: US$4.05 (vs US$3.53 in 2Q 2023)

Thermo Fisher Scientific Inc. Raises Earnings Guidance for the Year 2024

Now 20% overvalued after recent price rise

First quarter dividend of US$0.39 announced

Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology

Thermo Fisher Scientific Inc. (NYSE:TMO) completed the acquisition of Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others.

Thermo Fisher Scientific Inc. to Report Q2, 2024 Results on Jul 24, 2024

Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth-Defensive Index

Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies

Thermo Fisher Scientific Introduces Thermo Scientific Heracell VIOS 250i AxD CO2 Incubators

Upcoming dividend of US$0.39 per share

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation

First quarter dividend of US$0.39 announced

Thermo Fisher Scientific Inc. Declares Quarterly Dividend, Payable on July 15, 2024

Thermo Fisher Scientific Introduces Array-Based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions

First quarter 2024 earnings released: EPS: US$3.48 (vs US$3.34 in 1Q 2023)

Thermo Fisher Scientific Inc. Raises Revenue Guidance for the Full Year 2024

Thermo Fisher Scientific Inc. Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing

Thermo Fisher Scientific Inc., Annual General Meeting, May 22, 2024

Thermo Fisher Scientific Introduces Its Newest Line of High Performance, Ultra-Low Temperature (ULT) Freezers

Thermo Fisher Scientific Inc. to Report Q1, 2024 Results on Apr 24, 2024

Thermo Fisher Scientific Announces A New In-Line Metrology Solution to Improve Battery Safety and Performance

Thermo Fisher Scientific Inc. Launches Corevitas Clinical Registry in Generalized Pustular Psoriasis

Upcoming dividend of US$0.39 per share

Fourth quarter dividend of US$0.39 announced

Full year 2023 earnings released: EPS: US$15.53 (vs US$17.73 in FY 2022)

Thermo Fisher Scientific Inc. Increases Quarterly Cash Dividend, Payable on April 15, 2024

Independent Director recently sold Mex$1.5m worth of stock

Thermo Fisher Scientific Inc. Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs

Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing

Full year 2023 earnings released: EPS: US$15.53 (vs US$17.73 in FY 2022)

Thermo Fisher Scientific Inc. Announces Earnings Guidance for Full Year 2024

Thermo Fisher Scientific Appoints Srinath Venkatesh as Managing Director, India and South Asia

Thermo Fisher Scientific Receives GMP Approval from the Italian Medicines Agency for its Manufacturing Facility of RNA-Based Products in Monza, Italy

Thermo Fisher Scientific Inc. Announces Launch of Innovative Corevitas Pharmacovigilance Platform for Clinical Research Registries

Thermo Fisher Scientific Inc. Announces the Launch of the Thermo Scientific KingFisher Apex Dx and Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit

Upcoming dividend of US$0.35 per share at 0.3% yield

Thermo Fisher Scientific Declares Quarterly Dividend, Payable on January 16, 202

Thermo Fisher Scientific Announces New Fault Localization Solution for the Analysis of Advanced Logic Semiconductors

Thermo Fisher Scientific Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$4.44 (vs US$3.81 in 3Q 2022)

Thermo Fisher Scientific Inc. (NYSE:TMO) proposed an offer to acquire Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others for approximately $3.3 billion.

Thermo Fisher Scientific Inc. (NYSE:TMO) proposed an offer to acquire Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others for approximately $3.3 billion.

Thermo Fisher Scientific Inc. to Report Q3, 2023 Results on Oct 25, 2023

Thermo Fisher Scientific Inc. Appoints Jennifer “Jenny” Johnson to the Audit Committee